Clinical testing (n = 304) was performed using the Ashkenazi 3-site mutation panel (n = 5), BRCA1/2 sequencing (n = 142), Lynch syndrome testing (n = 1), and multi-gene panel testing (n = 156). Here, BRCA1 is linked to Lynch syndrome.